271 related articles for article (PubMed ID: 2363692)
1. Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.
Cole PA; Robinson CH
Biochem J; 1990 Jun; 268(3):553-61. PubMed ID: 2363692
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
[TBL] [Abstract][Full Text] [Related]
4. 3-Methylene-substituted androgens as novel aromatization inhibitors. Evidence of a requirement for C-3 oxygen in C-19 hydroxylations.
Miyairi S; Fishman J
J Biol Chem; 1986 May; 261(15):6772-7. PubMed ID: 3700413
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
Bednarski PJ; Nelson SD
J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P-450 and the aromatization of 16alpha-hydroxytestosterone and androstenedione by human placental microsomes.
Canick JA; Ryan KJ
Mol Cell Endocrinol; 1976 Dec; 6(2):105-15. PubMed ID: 1001810
[TBL] [Abstract][Full Text] [Related]
8. Competitive product inhibition of aromatase by natural estrogens.
Shimizu Y; Yarborough C; Osawa Y
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity of the placental microsomal aromatase.
Gibb W; Lavoie JC
Steroids; 1980 Nov; 36(5):507-19. PubMed ID: 7456098
[TBL] [Abstract][Full Text] [Related]
10. Determination of aromatization of 19-oxygenated 16 alpha-hydroxyandrostenedione with human placental microsomes by high-performance liquid chromatography coupled with coulometric detection.
Numazawa M; Konno T; Furihata R; Ishikawa S
J Steroid Biochem; 1990 Jul; 36(4):369-75. PubMed ID: 2391967
[TBL] [Abstract][Full Text] [Related]
11. Radiometric analysis of oxidative reactions in aromatization by placental microsomes. Presence of differential isotope effects.
Miyairi S; Fishman J
J Biol Chem; 1985 Jan; 260(1):320-5. PubMed ID: 3880740
[TBL] [Abstract][Full Text] [Related]
12. Aromatase reaction of 3-deoxyandrogens: steric mode of the C-19 oxygenation and cleavage of the C10-C19 bond by human placental aromatase.
Numazawa M; Nagaoka M; Sohtome N
Biochemistry; 2005 Aug; 44(32):10839-45. PubMed ID: 16086586
[TBL] [Abstract][Full Text] [Related]
13. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
Osawa Y; Higashiyama T; Shimizu Y; Yarborough C
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
[TBL] [Abstract][Full Text] [Related]
14. Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics.
Covey DF; Hood WF; Beusen DD; Carrell HL
Biochemistry; 1984 Nov; 23(23):5398-406. PubMed ID: 6509027
[TBL] [Abstract][Full Text] [Related]
15. Immunoaffinity purification of aromatase cytochrome P-450 from human placental microsomes, metabolic switching from aromatization to 1 beta and 2 beta-monohydroxylation, and recognition of aromatase isozymes.
Osawa Y; Yoshida N; Fronckowiak M; Kitawaki J
Steroids; 1987; 50(1-3):11-28. PubMed ID: 3142109
[TBL] [Abstract][Full Text] [Related]
16. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
Sethumadhavan K; Bellino FL
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of estrogen biosynthesis. Stereochemistry of C-1 hydrogen elimination in the aromatization of 2 beta-hydroxy-19-oxoandrostenedione.
Fishman J; Raju MS
J Biol Chem; 1981 May; 256(9):4472-7. PubMed ID: 7012154
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 stimulates the aromatase activity of human placental cytotrophoblasts.
Nestler JE
Endocrinology; 1993 Feb; 132(2):566-70. PubMed ID: 8425476
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic androgen assay: some properties of human placental microsomal aromatase.
Chikhaoui Y; Chitour F; Boussioux AM; Nicolas JC; Descomps B; Crastes de Paulet A
J Steroid Biochem; 1985 Jun; 22(6):727-31. PubMed ID: 3160890
[TBL] [Abstract][Full Text] [Related]
20. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
Furth PS; Robinson CH
Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
